Call for Expressions of Interest: Technology validation and commercial trials of Lipid-based microencapsulation technology for Lactoferrin

CSIR is seeking partners to conduct technology validation, commercial trials and license a benign encapsulation technology for lactoferrin using supercritical carbon dioxide, in a solvent-free, low-temperature environment. Co-development for product differentiation can also be undertaken where necessary.